Add-on Ayurvedic Treatment in the Management of Parkinson s Disease: A Clinical Study

Efficacy of Add-On Ayurvedic Treatment Protocol in the Management of Parkinson s Disease (Kampavata)- An Open-Labelled, Randomized Standard Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110781

Enrollment

Registered

2026-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the diagnostic criteria. 2.Modified Hoehn and Yahr staging (stage 1-3) 3.Age group of 40-75 years; irrespective of gender, religion, caste. 4.Patients who are willing and able to participate in the study. 5.Patients suitable for Basti and Nasya.

Exclusion criteria

Exclusion criteria: 1.Age below 40 and above 75 years. 2.Modified Hoehn and Yahr staging stage 4,5 3.More than one affected relative. 4.Repeated head injury (due to falls because of impaired balance) within 3 years of the disease. 5.A history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke, seizure or Severe Arrhythmia in last 6 months. 6.Patient suffering from type 1 DM, poorly controlled DM type II (RBS more than 200), poorly controlled HTN (Systolic BP more than or equal to 160 mmHg, Diastolic BP more than or equal to 100 mmHg). 7.Early severe autonomic involvement- Orthostatic hypotension (orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic, in the absence of dehydration, medication, or other diseases), Severe urinary incontinence or urinary retention in the first 5 years of disease (excluding longstanding low volume stress incontinence in women), which is not simply functional incontinence, In men, urinary retention must not be caused by prostate disease. 8.Early severe dementia.

Design outcomes

Primary

Measure	Time frame
1.Reduction in the severity-score on MDS-UPDRS (Movement Disorder Society-Unified Parkinson s Disease Rating Scale.) 2.Relief in the signs and symptoms of Parkinsons Disease (Kampavata)- as per assessment criteria. Timepoint: 10 weeks	—

Secondary

Measure	Time frame
1.Improvement in the quality of life of participants (assessed using PDQ-39 questionnaire).Timepoint: 10 weeks	—

Countries

India

Contacts

Public ContactVd Dhananjay V Patel

Institute of Teaching and Research in Ayurveda, Jamnagar

dvp@itra.edu.in9558805421

Outcome results